Do you want to read an article? Please log in or register.
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Central Nervous System Tumors
Related content
Gastrointestinal CancerSkin Cancer
Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management
Cancer Treat Rev.
Sznol M, Postow MA, Davies MJ, Pavlick AC, Plimack ER, Shaheen M, Veloski C, Robert C
doi: 10.1016/j.ctrv.2017.06.002.
Gastrointestinal Cancer
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study
JAMA Oncol.
Chen EX, Jonker DJ, Loree JM, Kennecke HF, Berry SR, Couture F, Ahmad CE, Goffin JR, Kavan P, Harb M, Colwell B, Samimi S, Samson B, Abbas T, Aucoin N, Aubin F, Koski SL, Wei AC, Magoski NM, Tu D, O'Callaghan CJ
doi: 10.1001/jamaoncol.2020.0910.
Lung, Respiratory and Thoracic Cancer
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma
Oncoimmunology
Budczies J, Kirchner M, Kluck K, Kazdal D, Glade J, Allgäuer M, Kriegsmann M, Heußel CP, Herth FJ, Winter H, Meister M, Muley T, Fröhling S, Peters S, Seliger B, Schirmacher P, Thomas M, Christopoulos P, Stenzinger A
doi: 10.1080/2162402X.2020.1860586
Further Publications
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer
JAMA Oncol.
Dolladille C, Ederhy S, Sassier M, Cautela J, Thuny F, Cohen AA, Fedrizzi S, Chrétien B, Da-Silva A, Plane AF, Legallois D, Milliez PU, Lelong-Boulouard V, Alexandre J
doi: 10.1001/jamaoncol.2020.0726.
Further Publications
Plinabulin, a Distinct Microtubule-Targeting Chemotherapy, Promotes M1-Like Macrophage Polarization and Anti-tumor Immunity
Front Oncol
Natoli M, Herzig P, Pishali Bejestani E, Buchi M, Ritschard R, Lloyd GK, Mohanlal R, Tonra JR, Huang L, Heinzelmann V, Trüb M, Zippelius A, Kashyap AS
doi: 10.3389/fonc.2021.644608
Further Publications
Association between immune-related adverse events and long-term survival outcomes in patients treated with immune checkpoint inhibitors
Eur J Cancer.
Maillet D, Corbaux P, Stelmes JJ, Dalle S, Locatelli-Sanchez M, Perier-Muzet M, Duruisseaux M, Kiakouama-Maleka L, Freyer G, Boespflug A, Péron J
doi: 10.1016/j.ejca.2020.03.017.
Lung, Respiratory and Thoracic Cancer
Moving immune checkpoint blockade in thoracic tumors beyond non-small cell lung cancer
J Thorac Oncol.
Facchinetti F, Marabelle A, Rossi G, Soria JC, Besse B, Tiseo M
doi: 10.1016/j.jtho.2016.05.027
Genitourinary CancerSkin Cancer
Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A review
Eur J Cancer
Larroquette M, Domblides C, Lefort F, Lasserre M, Quivy A, Sionneau B, Bertolaso P, Gross-Goupil M, Ravaud A, Daste A
doi: 10.1016/j.ejca.2021.09.013
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Relationship between pneumonitis induced by immune checkpoint inhibitors and the underlying parenchymal status: a retrospective study
★ 1
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
doi: 10.1183/23120541.00165-2019.